Stomach Cancer Trial, Recruiting (NCT06984952)

Stomach Cancer Trial, Recruiting NCT06984952 Sponsor: Seoul National University Hospital Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06984952 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 19 years or older who are planning to have a scheduled laparoscopic or robotic surgery to remove part or all of the stomach for stomach cancer
People who are considered to be in generally good to moderate overall health based on a standard medical assessment (rated Class I to III by an anesthesiologist)
People who are able to give written consent, understand how the study works, and complete questionnaires about how they are feeling

Who may not be able to join:

People who need to have organs other than the stomach removed during the same surgery (except for the gallbladder)
People who have previously had surgery on the upper part of their abdomen (except for gallbladder removal)
People who have a known allergy or sensitivity to any of these medications: fentanyl, ropivacaine, acetaminophen (paracetamol), or anti-inflammatory pain medicines (such as ibuprofen)
People who the study team decides are not suitable for the trial for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Do Joong Park, MD, PhD, Seoul National University Hospital

Phone: 82-2-2072-2467

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06984952

Sponsor: Seoul National University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Stomach Cancer

Trial contact: 82-2-2072-2467

More information: https://clinicaltrials.gov/study/NCT06984952

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 19 years or older who are planning to have a scheduled laparoscopic or robotic surgery to remove part or all of the stomach for stomach cancer
People who are considered to be in generally good to moderate overall health based on a standard medical assessment (rated Class I to III by an anesthesiologist)
People who are able to give written consent, understand how the study works, and complete questionnaires about how they are feeling

Who may not be able to join:

People who need to have organs other than the stomach removed during the same surgery (except for the gallbladder)
People who have previously had surgery on the upper part of their abdomen (except for gallbladder removal)
People who have a known allergy or sensitivity to any of these medications: fentanyl, ropivacaine, acetaminophen (paracetamol), or anti-inflammatory pain medicines (such as ibuprofen)
People who the study team decides are not suitable for the trial for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Seoul National University Hospital

Registry

ClinicalTrials.gov

Start date

13 June 2025

Est. completion

31 December 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Proportion of patients who fulfilled all of the predefined discharge criteria

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov